GL1X · GenesisL1 explorer

Research workbench

Pyranose 2-oxidase H450G mutant with 2-fluorinated galactose

Analyse Pyranose 2-oxidase H450G mutant with 2-fluorinated galactose in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4MOO
Type
protein
Length
576 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Pyranose 2-oxidase
EC
1.1.3.10
UniProt
Q7ZA32
Ligands
FDA, GAF
Pockets
4 · best druggability 0.88

Structure

x-ray diffraction · 1 distinct chain · 24% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APyranose 2-oxidase (EC 1.1.3.10)protein57624% helix, 23% strandQ7ZA32

Ligands and binding sites

  • FDA · Dihydroflavine-adenine dinucleotide · ligand · chains A
  • GAF · 2-deoxy-2-fluoro-alpha-D-galactopyranose · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14930.880.9565FDA, GAF
24340.730.8357empty
3960.510.8224empty
4890.350.7412empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 4MOO · Pyranose 2-oxidase H450G mutant with 2-fluorinated galactose · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.